SNDL
SNDL
NASDAQ · Pharmaceuticals

Sndl Inc

$1.42
+0.04 (+2.54%)
As of Nov 7, 2:06 AM ET ·
Financial Highlights (FY 2026)
Revenue
892.38M
Net Income
-14,866,890
Gross Margin
27.3%
Profit Margin
-1.7%
Rev Growth
+9.9%
D/E Ratio
0.15
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 27.3% 27.3% 64.3% 64.3%
Operating Margin -0.8% -0.8% 39.2% 39.7%
Profit Margin -1.7% -1.6% 27.9% 35.0%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 892.38M 811.70M 59.12M 71.20M
Gross Profit 243.89M 221.84M 38.02M 45.80M
Operating Income -7,585,216 -6,209,472 23.17M 28.28M
Net Income -14,866,890 -12,170,457 16.50M 24.90M
Gross Margin 27.3% 27.3% 64.3% 64.3%
Operating Margin -0.8% -0.8% 39.2% 39.7%
Profit Margin -1.7% -1.6% 27.9% 35.0%
Rev Growth +9.9% +9.9% +13.8% -7.0%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 23.01M 23.01M 55.29M 58.47M
Total Equity 149.14M 149.14M 239.97M 225.54M
D/E Ratio 0.15 0.15 0.23 0.26
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA 41.44M 35.81M 25.74M 34.11M
Free Cash Flow — — 14.78M 25.53M